Patents by Inventor John B. Cheng

John B. Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240097346
    Abstract: Methods for constructing multi-walled carbon nanotube (MWCNT) antenna arrays, may include: variable doping of the MWCNTs, forming light pipes with layers of variable dielectric glass, forming geometric diodes on full-wave rectified devices that propagate both electrons and holes, using clear conductive ground plans to form windows that can control a building's internal temperature, and generating multiple lithographic patterns with a single mask.
    Type: Application
    Filed: November 21, 2023
    Publication date: March 21, 2024
    Inventors: Laurence H. COOKE, Darin S. OLSON, Paul COMITA, Robert E. COUSINS, Albert K. HENNING, Andreas HEGEDUS, David B. COOKE, Yao Te CHENG, John BURKE, Richard T. PRESTON
  • Patent number: 6878522
    Abstract: The present invention relates to the discovery that PDG2 is the nautral ligand for orphan receptor CRTH2, which interaction, it will now immediately be recognized, is important in the development of valuable pharmaceuticals. The present invention is therefore related to methods for screening for therapeutic compounds useful in the treatment of PGD2-related disorders such as allergy, asthma and inflammation. Appropriate assay methodology is also disclosed.
    Type: Grant
    Filed: April 11, 2001
    Date of Patent: April 12, 2005
    Inventors: Baiyong Li, Kuldeep S. Neote, Ronald P. Gladue, John B. Cheng, Paul H. Bauer, Jiansu Zhang
  • Patent number: 6380218
    Abstract: A compound of formula (I) wherein m, n, o, p, q, r, A, B, D, E, R1, R2,R3, R4, R5, R6, R7 and R8 are as defined in the description, useful in the treatment of respiratory, allergic, rheumatoid, body weight regulation, inflammatory and central nervous system disorders such as asthma, chronic obstructive pulmonary disease, adult respiratory diseases syndrome, shock, fibrosis, pulmonary hypersensitivity, allergic rhinitis, atopic dermatitis, psoriasis, weight control, rheumatoid arthritis, cachexia, crohn's disease, ulcerative colitis, arthritic conditions and other inflammatory diseases, depression, multi-infarct dementia and AIDS.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: April 30, 2002
    Assignee: Pfizer Inc
    Inventors: Anthony Marfat, Robert J. Chambers, John W. Watson, John B. Cheng, Allen J. Duplantier, Edward F. Kleinman
  • Patent number: 5461056
    Abstract: Racemic or optically active compound of the formula ##STR1## wherein X, Y, R.sup.1 and R.sup.2 are as defined above useful in the treatment of asthma or inflammatory airway or skin diseases.
    Type: Grant
    Filed: May 3, 1994
    Date of Patent: October 24, 1995
    Assignee: Pfizer Inc.
    Inventor: John B. Cheng
  • Patent number: 5342842
    Abstract: Racemic or optically active compound of the formula ##STR1## wherein X is O or NH, R.sup.1 is a (C.sub.7 -C.sub.11)polycycloalkyl group, R.sup.2 is methyl or ethyl, Y is ##STR2## R.sup.3 is hydrogen, (C.sub.1 -C.sub.3)alkyl, (C.sub.2 -C.sub.3)alkenyl, benzyl or phenethyl, and R.sup.4 is hydrogen, (C.sub.1 -C.sub.3)alkyl or (C.sub.2 -C.sub.3)alkanoyl, are useful in the treatment of asthma or inflammatory airway or skin diseases.
    Type: Grant
    Filed: May 8, 1992
    Date of Patent: August 30, 1994
    Assignee: Pfizer Inc.
    Inventor: John B. Cheng